Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Net Income (2019 - 2025)

Historic Net Income for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to -$18.1 million.

  • Korro Bio's Net Income rose 1399.11% to -$18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$88.5 million, marking a year-over-year decrease of 76.19%. This contributed to the annual value of -$83.6 million for FY2024, which is 304.17% down from last year.
  • Latest data reveals that Korro Bio reported Net Income of -$18.1 million as of Q3 2025, which was up 1399.11% from -$25.8 million recorded in Q2 2025.
  • Korro Bio's Net Income's 5-year high stood at $6.2 million during Q4 2022, with a 5-year trough of -$25.8 million in Q2 2025.
  • For the 5-year period, Korro Bio's Net Income averaged around -$19.7 million, with its median value being -$21.0 million (2024).
  • Its Net Income has fluctuated over the past 5 years, first soared by 12877.21% in 2022, then crashed by 51102.49% in 2023.
  • Over the past 5 years, Korro Bio's Net Income (Quarter) stood at -$21.5 million in 2021, then skyrocketed by 128.77% to $6.2 million in 2022, then tumbled by 511.02% to -$25.4 million in 2023, then rose by 16.39% to -$21.3 million in 2024, then increased by 15.04% to -$18.1 million in 2025.
  • Its Net Income was -$18.1 million in Q3 2025, compared to -$25.8 million in Q2 2025 and -$23.4 million in Q1 2025.